These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 29263650

  • 21. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J, Ren Y, Ma J, Luo X, Li J, Wu Y, Gu H, Fu C, Cao Z, Zhang J.
    J Nanobiotechnology; 2021 Jun 23; 19(1):188. PubMed ID: 34162396
    [Abstract] [Full Text] [Related]

  • 22. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
    Jia X, Yin J, He D, He X, Wang K, Chen M, Li Y.
    J Biomed Nanotechnol; 2013 Dec 23; 9(12):2063-72. PubMed ID: 24266261
    [Abstract] [Full Text] [Related]

  • 23. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B, Mittal NK, Balabathula P, Thoma LA, Wood GC.
    Eur J Pharm Sci; 2016 Jan 01; 81():162-71. PubMed ID: 26517962
    [Abstract] [Full Text] [Related]

  • 24. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
    Kabary DM, Helmy MW, Elkhodairy KA, Fang JY, Elzoghby AO.
    Colloids Surf B Biointerfaces; 2018 Sep 01; 169():183-194. PubMed ID: 29775813
    [Abstract] [Full Text] [Related]

  • 25. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X, Liu Y, Guo M, Fei W, Zheng H, Zhang R, Zhang Y, Wei Y, Zheng G, Li F.
    J Biomater Appl; 2016 Jul 01; 31(1):23-35. PubMed ID: 27059495
    [Abstract] [Full Text] [Related]

  • 26. Near-Infrared Light and pH-Responsive Polypyrrole@Polyacrylic acid/Fluorescent Mesoporous Silica Nanoparticles for Imaging and Chemo-Photothermal Cancer Therapy.
    Zhang M, Wang T, Zhang L, Li L, Wang C.
    Chemistry; 2015 Nov 02; 21(45):16162-71. PubMed ID: 26494031
    [Abstract] [Full Text] [Related]

  • 27. A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization.
    Samiei Foroushani M, Niroumand N, Karimi Shervedani R, Yaghoobi F, Kefayat A, Torabi M.
    Bioelectrochemistry; 2019 Dec 02; 130():107347. PubMed ID: 31437809
    [Abstract] [Full Text] [Related]

  • 28. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y, Che S, Hui B, Yang Y, Wang X, Zhang X, Qiang Y, Ma H.
    Biomed Pharmacother; 2019 Apr 02; 112():108614. PubMed ID: 30798129
    [Abstract] [Full Text] [Related]

  • 29. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L, Liu X, Li J, Li W, Zhang L, Fu C, Zhang J, Gu Z.
    Theranostics; 2021 Apr 02; 11(9):4171-4186. PubMed ID: 33754055
    [Abstract] [Full Text] [Related]

  • 30. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D, Zhu ZQ, Tang HX, Shi ZE, Kang J, Liu Q, Qi J.
    Theranostics; 2020 Apr 02; 10(21):9808-9829. PubMed ID: 32863961
    [Abstract] [Full Text] [Related]

  • 31. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
    Li D, Huang X, Wu Y, Li J, Cheng W, He J, Tian H, Huang Y.
    Biomater Sci; 2016 Feb 02; 4(2):272-80. PubMed ID: 26484364
    [Abstract] [Full Text] [Related]

  • 32. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q, Zhang M, Zhang Z, Shen W, Liu L, Zhang Q.
    Int J Pharm; 2014 Oct 20; 474(1-2):232-40. PubMed ID: 25149124
    [Abstract] [Full Text] [Related]

  • 33. Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery.
    Wang L, You X, Lou Q, He S, Zhang J, Dai C, Zhao M, Zhao M, Hu H, Wu J.
    Biomater Sci; 2019 Oct 01; 7(10):4218-4229. PubMed ID: 31389415
    [Abstract] [Full Text] [Related]

  • 34. Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer.
    Li Z, Zhu L, Liu W, Zheng Y, Li X, Ye J, Li B, Chen H, Gao Y.
    Acta Biomater; 2020 Apr 15; 107():242-259. PubMed ID: 32151700
    [Abstract] [Full Text] [Related]

  • 35. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN3-Derived Lipid for Synergistic Lung Cancer Therapy.
    Liang YX, Sun XY, Xu DZ, Gao YN, Tang Q, Lu ZL, Liu Y.
    ACS Appl Bio Mater; 2024 May 20; 7(5):3202-3214. PubMed ID: 38651918
    [Abstract] [Full Text] [Related]

  • 36. Design of Lamivudine Loaded Nanoparticles for Oral Application by Nano Spray Drying Method: A New Approach to use an Antiretroviral Drug for Lung Cancer Treatment.
    Öztürk AA, Namlı İ, Güleç K, Görgülü Ş.
    Comb Chem High Throughput Screen; 2020 May 20; 23(10):1064-1079. PubMed ID: 32209039
    [Abstract] [Full Text] [Related]

  • 37. Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.
    Cao C, Wang Q, Liu Y.
    Drug Des Devel Ther; 2019 May 20; 13():1087-1098. PubMed ID: 31118562
    [Abstract] [Full Text] [Related]

  • 38. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
    Qu J, Wang R, Peng S, Shi M, Yang ST, Luo JB, Lin J, Zhou QH.
    J Mater Chem B; 2019 Dec 07; 7(45):7129-7140. PubMed ID: 31663585
    [Abstract] [Full Text] [Related]

  • 39. Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells.
    Conte C, Monteiro PF, Gurnani P, Stolnik S, Ungaro F, Quaglia F, Clarke P, Grabowska A, Kavallaris M, Alexander C.
    Nanoscale; 2021 Jul 08; 13(26):11414-11426. PubMed ID: 34160534
    [Abstract] [Full Text] [Related]

  • 40. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
    Cabeza L, Ortiz R, Prados J, Delgado ÁV, Martín-Villena MJ, Clares B, Perazzoli G, Entrena JM, Melguizo C, Arias JL.
    Eur J Pharm Sci; 2017 May 01; 102():24-34. PubMed ID: 28219748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.